Indian companies set to launch Novo Wegovy generics for as low as $14

1 day ago

High CTR Ad

Comments

Young man as a doctor gives a medical injection to Indian flag on a black background

With a key patent on Novo Nordisk's (NVO) GLP-1 semaglutide set to expire on Friday in the country, more than 10 Indian pharmaceutical companies are gearing up to launch generics of Wegovy and Ozempic for as cheap as $14 a month.

Source India

↑